Earvin Liang
Impact in
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Advanced biosensing and bioanalysis techniques 3
- RNA Interference and Gene Delivery 3
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Mehran Yazdanian (4 shared papers)Jeff Hughes (2 shared papers)John Proudfoot (1 shared paper)Steven M. Dinh (1 shared paper)Alisa K. Kabcenell (1 shared paper)John A. Robson (1 shared paper)Hartmut Derendorf (1 shared paper)Jeffrey A. Hughes (1 shared paper)
- Journals
- Alzheimer s & Dementia (5 papers)Journal of Pharmaceutical Sciences (2 papers)International Journal of Pharmaceutics (1 paper)Neurology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Earvin Liang
18 papers receiving 344 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 47
- Oncology 94
- Pharmacology 22
- Molecular Biology 148
- Spectroscopy 35
Countries citing papers authored by Earvin Liang
This map shows the geographic impact of Earvin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earvin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earvin Liang more than expected).
Fields of papers citing papers by Earvin Liang
This network shows the impact of papers produced by Earvin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earvin Liang. The network helps show where Earvin Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Earvin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 75 | |
| 2 | 2000 | 63 | |
| 3 | 1998 | 51 | |
| 4 | 2001 | 33 | |
| 5 | 2007 | 31 | |
| 6 | 2000 | 25 | |
| 7 | 2000 | 15 | |
| 8 | 2017 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 1998 | 10 | |
| 11 | 2013 | 10 | |
| 12 | 2003 | 6 | |
| 13 | 2011 | 3 | |
| 14 | 2000 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2009 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2011 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2012 | 0 |
About Earvin Liang
Earvin Liang is a scholar working on Molecular Biology, Oncology, Physiology, Pharmacology and Plant Science, having authored 20 papers that have together received 353 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), RNA Interference and Gene Delivery (3 papers), Phytase and its Applications (3 papers), Cancer Treatment and Pharmacology (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Pharmaceutical Science (47 citations), Oncology (94 citations), Pharmacology (22 citations), Molecular Biology (148 citations) and Spectroscopy (35 citations). Earvin Liang has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Mehran Yazdanian, Jeff Hughes, John Proudfoot, Steven M. Dinh, Alisa K. Kabcenell, John A. Robson, Hartmut Derendorf, Jeffrey A. Hughes, Suresh K. Alahari and R. L. Juliano. Their work appears in journals such as Alzheimer s & Dementia, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, Neurology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.